Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer
Clinical trial NCT05569187 · COMPLETED
Trial details
- NCT number
- NCT05569187
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-23
- Primary completion
- 2021-10-29
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.